Back
Polygenic Risk Scores for Prostate Cancer Risk Stratification - Lessons From the BARCODE1 Study
Wednesday, January 27, 2027 at 12:30 PM to 1:00 PM · 30 min. (Europe/London)
Cancer Diagnostics Stage
Day 1 - Wednesday 27th January
Cancer
Diagnostics
Polygenic Risk Scores
Precision Medicine
Information
This session will cover:
The latest evidence supporting the use of polygenic risk scores for prostate cancer risk stratification.
Key findings from the BARCODE1 study and what they reveal about targeted screening approaches.
How genetic risk stratification could improve targeting of early detection and assessment of overdiagnosis
The opportunities and challenges associated with integrating polygenic risk scores into routine healthcare.
What long-term follow-up data can tell us about the clinical utility of risk-based prostate cancer screening.
Speakers
Rosalind Eeles
Professor of Oncogenetics
The Institute of Cancer Research